| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.23 | 5e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.0009 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.18 | 0.0009 |